MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in behcet's disease

Journal of Proteome Research

Volumn 7, Issue 10, 2008, Pages 4500-4507

  Mao, Liming ^a   Dong, Hongtao ^a   Yang, Peizeng ^b,e   Zhou, Hongyan ^a   Huang, Xiangkun ^a   Lin, Xiaomin ^a   Kijlstra, Aize ^c,d  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e NONE   (China)

Author keywords

Behcet's disease; Hp; SAA; Serum; Vkh syndrome

Indexed keywords

ALBUMIN; AMYLOID A PROTEIN; HAPTOGLOBIN; IMMUNOGLOBULIN G; SERUM AMYLOID A;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; VOGT KOYANAGI SYNDROME; WESTERN BLOTTING; BLOOD; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; REPRODUCIBILITY;

ADULT; BEHCET SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SERUM AMYLOID A PROTEIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 55949099265     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800279m     Document Type: Article

References (52)

1. Sakane, T.; Takeno, M.; Suzuki, N.; Inaba, G. Behcet's disease. N. Engl. J. Med. 1999, 341 (17), 1284-91.
2. Gul, A.; Hajeer, A. H.; Worthington, J.; Oilier, W. E.; Silman, A. J. Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23. Arthritis Rheum. 2001, 44 (11), 2693-6.
3. Eglin, R. P.; Lehner, T.; Subak-Sharpe, J. H. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet 1982, 2 (8312), 1356-61.
4. Lehner, T. Behcet's syndrome and autoimmunity. Br. Med. J. 1967, 1 (5538), 465-7.
5. Kaneko, S.; Suzuki, N.; Yamashita, N.; Nagafuchi, H.; Nakajima, T.; Wakisaka, S.; Yamamoto, S.; Sakane, T. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin. Exp. Immunol. 1997, 108 (2), 204-12.
6. Kozak, K. R.; Su, F.; Whitelegge, J. P.; Faull, K.; Reddy, S.; Farias-Eisner, R. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 2005, 5 (17), 4589-96.
7. Steel, L. F.; Shumpert, D.; Trotter, M.; Seeholzer, S. H.; Evans, A. A.; London, W. T.; Dwek, R.; Block, T. M. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 2003, 3 (5), 601-9.
8. Feng, J. T.; Liu, Y. K.; Song, H. Y.; Dai, Z.; Qin, L. X.; Almofti, M. R.; Fang, C. Y.; Lu, H. J.; Yang, P. Y.; Tang, Z. Y. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 2005, 5 (17), 4581-8.
9. Xiao, X.; Liu, D.; Tang, Y.; Guo, F.; Xia, L.; Liu, J.; He, D. Development of proteomic patterns for detecting lung cancer. Dis. Markers 2003, 19 (1), 33-9.
10. Miyamae, T.; Malehorn, D. E.; Lemster, B.; Mori, M.; Imagawa, T.; Yokota, S.; Bigbee, W. L.; Welsh, M.; Klarskov, K.; Nishomoto, N.; Vallejo, A. N.; Hirsch, R. Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. Arthritis Res. Ther. 2005, 7 (4), R746-55.
11. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990, 335, (8697), 1078-80.
12. Read, R. W.; Holland, G. N.; Rao, N. A.; Tabbara, K. F.; Ohno, S.; Arellanes-Garcia, L.; Pivetti-Pezzi, P.; Tessler, H. H.; Usui, M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am. J. Ophthalmol. 2001, 131 (5), 647-52.
13. Candiano, G.; Bruschi, M.; Musante, L.; Santucci, L.; Ghiggeri, G. M.; Carnemolla, B.; Orecchia, P.; Zardi, L.; Righetti, P. G. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25 (9), 1327-33.
14. Thongboonkerd, V.; Klein, J. B. Practical bioinformatics for proteomics. Contrib. Nephrol. 2004, 141, 79-92.
15. Le Naour, F.; Misek, D. E.; Krause, M. C.; Deneux, L.; Giordano, T. J.; Scholl, S.; Hanash, S. M. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res. 2001, 7 (11), 3328-35.
16. Anderson, N. L.; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1 (11), 845-67.
17. Chromy, B. A.; Gonzales, A. D.; Perkins, J.; Choi, M. W.; Corzett, M. H.; Chang, B. C.; Corzett, C. H.; McCutchen-Maloney, S. L. Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins. J. Proteome Res. 2004, 3 (6), 1120-7.
18. Ahmed, N.; Barker, G.; Oliva, K.; Garfin, D.; Talmadge, K.; Georgiou, H.; Quinn, M.; Rice, G. An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics 2003, 3 (10), 1980-7.
19. Drake, R. R.; Schwegler, E. E.; Malik, G.; Diaz, J.; Block, T.; Mehta, A.; Semmes, O. J. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol. Cell. Proteomics 2006, 5 (10), 1957-67.
20. Ramstrom, M.; Hagman, C.; Mitchell, J. SC.; Derrick, P. J.; Hakansson, P.; Bergquist, J. Depletion of high-abundant proteins in body fluids prior to liquid chromatography fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 2005, 4 (2), 410-6.
21. Schussler, G. C. The thyroxine-binding proteins. Thyroid 2000, 10 (2), 141-9.
22. Curry, S. Beyond expansion: structural studies on the transport roles of human serum albumin. Vox Sang. 2002, 83 (1), 315-9.
23. Dea, M. K.; Hamilton-Wessler, M.; Ader, M.; Moore, D.; Schaffer, L.; Loftager, M.; Volund, A.; Bergman, R. N. Albumin binding of acylated insulin (NN304) does not deter action to stimulate glucose uptake. Diabetes 2002, 51 (3), 762-9.
24. Patron, W. F. Detection technologies in proteome analysis. J. Chromatogr., B:Anal. Technol. Biomed. Life Sci. 2002, 771 (1-2), 3-31.
25. Baykan, M.; Celik, S.; Erdol, C.; Baykan, E. C.; Durmus, I.; Bahadir, S.; Erdol, H.; Orem, C.; Cakirbay, H. Behcet's disease with a large intracardiac thrombus: a case report. Heart 2001, 85 (4), E7.
26. Lee, K. H.; Kim, FL; Lee, S.; Bang, D. Comparison of proteome map between sera of patients with Behcet's disease and controls. Adv. Exp. Med. Biol. 2003, 528, 213-5.
27. Aygunduz, M.; Bavbek, N.; Ozturk, M.; Kaftan, O.; Kosar, A.; Kirazli, S. Serum beta 2-microglobulin reflects disease activity in Behcet's disease. Rheumatol. Int. 2002, 22 (1), 5-8.
28. Zvi, B.; Levy, A. P. Haptoglobin phenotypes, which one is better and when. Clin. Lab. 2006, 52 (1-2), 29-35.
29. Lim, S. K.; Ferraro, B.; Moore, K.; Halliwell, B. Role of haptoglobin in free hemoglobin metabolism. Redox Rep. 2001, 6 (4), 219-27.
30. Arredouani, M.; Matthys, P.; Kasran, A.; Baumann, H.; Ceuppen, J. L. Haptoglobin and the Thl/Th2 balance: hints from in vitro and in vivo studies. Redox Rep. 2001, 6 (6), 369-71.
31. Arredouani, M.; Matthijs, P.; Van Hoeyveld, E.; Kasran, A.; Baumann, H.; Ceuppens, J. L.; Stevens, E. Haptoglobin directiy affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 2003, 108 (2), 144-51.
32. Dhaliwal, G.; Cornett, P. A.; Tierney, L. M., Jr. Hemolytic anemia. Am. Fam. Physician 2004, 69 (11), 2599-606.
33. Pavon, E. J.; Munoz, P.; Lario, A.; Longobardo, V.; Carrascal, M.; Abian, J.; Martin, A. B.; Arias, S. A.; Callejas-Rubio, J. L.; Sola, R.; Navarro-Pelayo, F.; Raya-Alvarez, E.; Ortego-Centeno, N.; Zubiaur, M.; Sancho, J. Proteomic analysis of plasma from patients with systemic lupus erythematosus: Increased presence of haptoglobin alpha2 polypeptide chains over the alphal isoforms. Proteomics 2006, 6 (1), S282-92.
34. Pantoni, L.; Inzitari, D. Abnormal penetration of haptoglobin through the blood-brain-barrier (BBB) into the cerebro-spinal fluid (CSF) in Alzheimer's disease patients. Acta Neurol. Scand. 1995, 91 (3), 225.
35. Takeoka, T.; Shinohara, Y.; Furumi, K.; Mori, K. Impairment of blood-cerebrospinal fluid barrier in multiple sclerosis. J. Neurochem. 1983, 41 (4), 1102-8.
36. Chang, K. H.; Lyu, R. K.; Tseng, M. Y.; Ro, L. S.; Wu, Y. R.; Chang, H. S.; Hsu, W. C.; Kuo, H. C.; Huang, C. C.; Chu, C. C.; Hsieh, S. Y; Chen, C. M. Elevated haptoglobin level of cerebrospinal fluid in Guillain-Barre syndrome revealed by proteomics analysis. Proteomics Clin. Appl. 2007, 1 (5), 467-75.
37. Abbas, A. K.; Murphy, K. M; Sher, A. Functional diversity of helper T lymphocytes. Nature 1996, 383 (6603), 787-93.
38. Suzuki, N.; Nara, K.; Suzuki, T. Skewed Thl responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease. Clin. Med. Res. 2006, 4 (2), 147-51.
39. Song, H. K.; Noorchashm, H.; Lin, T. H.; Moore, D. J.; Greeley, S. A.; Caton, A. J.; Naji, A. Specialized CC-chemokine secretion by Thl cells in destructive autoimmune myocarditis. J. Autoimmun. 2003, 21 (4), 295-303.
40. Raynes, J. G.; Eagling, S.; McAdam, K. P. Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and inteleukin-6. Clin. Exp. Immunol. 1991, 83 (3), 488-91.
41. He, R.; Sang, H.; Ye, R. D. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Btood 2003, 101 (4), 1572-81.
42. Furlaneto, C. J.; Campa, A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-lbeta, and interleukin-8 by human blood neutrophil. Biochem. Biophys. Res. Commun. 2000, 268 (2), 405-8.
43. He, R.; Shepard, L. W.; Chen, J.; Pan, Z. K.; Ye, R. D. Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. J. Immunol. 2006, 177 (6), 4072-9.
44. Patel, H.; Fellowes, R.; Coade, S.; Woo, P. Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 1998, 48 (4), 410-8.
45. Vallon, R.; Freuler, F.; Desta-Tsedu, N.; Robeva, A.; Dawson, J.; Wenner, P.; Engelhardt, P.; Boes, L.; Schnyder, J.; Tschopp, C.; Urfer, R.; Baumann, G. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 2001, 166 (4), 2801-7.
46. Hirooka, Y.; Mitsuma, T.; Nogimori, T.; Ishizuki, Y. Deregulated production of interleukin-8 (IL-8) in autoimmune thyroid disease studied by newly developed IL-8 radioimmunoassay. Endocr. Regul. 1993, 27(1), 11-5.
47. Xiao, B. G.; Ma, C. G.; Xu, L. Y.; Link, H.; Lu, C. Z. IL-12/IFN- gamma/NO axis plays critical role in development of Thl- mediated experimental autoimmune encephalomyelitis. Mol. Immunol. 2008, 45 (4), 1191-6.
48. Thakker, P.; Leach, M. W.; Kuang, W.; Benoit, S. E.; Leonard, J. P.; Marusic, S. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178 (4), 2589-98.
49. Wachlin, G.; Augstein, P.; Schroder, D.; Kuttler, B.; Kloting, I.; Heinke, P.; Schmidt, S. IL-lbeta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction. J. Autoimmun. 2003, 20 (4), 303-12.
50. Tang, Q.; Huang, J.; Qian, H.; Xiong, R.; Shen, D.; Wu, H.; Bian, Z.; Wei, X. Microarray analysis reveals the role of matrix metalloproteinases in mouse experimental autoimmune myocarditis induced by cardiac myosin peptides. Cell. Mol. Biol. Lett. 2007, 12 (2), 176-91.
51. Sodin-Semrl, S.; Zigon, P.; Cucnik, S.; Kveder, T.; Blinc, A.; Tomsic, M.; Rozman, B. Serum amyloid A in autoimmune thrombosis. Autoimmun. Rev. 2006, 6 (1), 21-7.
52. Wong, M.; Toh, L.; Wilson, A.; Rowley, K.; Karschimkus, C.; Prior, D.; Romas, E.; Clemens, L.; Dragicevic, G.; Harianto, H.; Wicks, I.; McColl, G.; Best, I.; Jenkins, A. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum. 2003, 48 (1), 81-9.